← Leaderboards
Kalil G Abdullah
Ut Southwestern Medical Center
$1,835,946
Attributed
$3,671,892
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,671,892 · 3
By mechanism
R01$3,671,892 · 3
Top collaborators
- Samuel Kent Mcbrayer6 shared
- Jeremy N Rich2 shared
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Margaret A. Phillips$30,430,817
- Samuel Kent McBrayer$5,142,431
- Thomas J Wang$21,119,622
- Milan Rashmin Savani$170,755
- Gerta N/a Hoxhaj$2,384,478
Others in their field
Other Emerging Leaders on “Brain Neoplasms”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- Greg Yothers · University Of Chicago$35,003,821
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,459,738
- Crystal Mackall · Children'S Hosp Of Philadelphia$13,823,781
- Olwen Hahn · Brigham And Women'S Hospital$13,557,463
- Jennifer Cohen Price · University Of California, San Francisco$9,197,178
Research focus
Brain NeoplasmsMolecularTumor GrowthNeoplastic CellEnzymesPathogenesisTranslatingTumorIn VivoCellsMetabolismBrainMalignant NeoplasmsMetabolicMetabolic PathwayClinical TranslationClinical TrialsOrganoidsGlioblastomaCatabolismGene ExpressionGeneticFoundationsDependence
Grant awards (8)
Metabolic mechanisms of glioma progression$682,596
R01 · FY2025 · CA
Targeting Amino Acid Metabolism in Glioblastoma$565,760
R01 · FY2025 · NS
Exploiting Pyrimidine Nucleotide Synthesis Dependence for IDH Mutant Glioma Therapy$375,150
R01 · FY2025 · CA
Targeting Amino Acid Metabolism in Glioblastoma$574,427
R01 · FY2024 · NS
Exploiting Pyrimidine Nucleotide Synthesis Dependence for IDH Mutant Glioma Therapy$356,393
R01 · FY2024 · CA
Exploiting Pyrimidine Nucleotide Synthesis Dependence for IDH Mutant Glioma Therapy$367,647
R01 · FY2023 · CA
Exploiting Pyrimidine Nucleotide Synthesis Dependence for IDH Mutant Glioma Therapy$375,150
R01 · FY2022 · CA
Exploiting Pyrimidine Nucleotide Synthesis Dependence for IDH Mutant Glioma Therapy$374,769
R01 · FY2021 · CA